Human primary airway epithelial cells isolated from active smokers have epigenetically impaired antiviral responses by unknown
RESEARCH Open Access
Human primary airway epithelial cells
isolated from active smokers have
epigenetically impaired antiviral responses
Wenxin Wu1, Wei Zhang1, J. Leland Booth1, David C. Hutchings2, Xiaoqiu Wang1, Vicky L. White4,
Houssein Youness1, Cory D. Cross1, Ming-Hui Zou3, Dennis Burian4 and Jordan P. Metcalf1,5,6*
Abstract
Background: Cigarette smoking (CS) is the main risk factor for the development of chronic obstructive pulmonary
disease (COPD) and most COPD exacerbations are caused by respiratory infections including influenza. Influenza
infections are more severe in smokers. The mechanism of the increased risk and severity of infections in smokers is
likely multifactorial, but certainly includes changes in immunologic host defenses.
Methods: We investigated retinoic acid-inducible protein I (RIG-I) and interferon (IFN) induction by influenza A virus
(IAV) in human bronchial epithelial cells (HBEC) isolated from smokers or nonsmokers. Subcultured HBEC cells were
infected with A/Puerto Rico/8/1934 (PR8) IAV at an MOI of 1. After 24 h of infection, cells and supernatants were
collected for qRT-PCR, immunoblot or ELISA to determine RIG-I, Toll-like receptor3 (TLR3) and IFN expression levels.
Results: IAV exposure induced a vigorous IFN-β, IFN-λ 1 and IFN-λ 2/3 antiviral response in HBEC from nonsmokers
and significant induction of RIG-I and TLR3. In cells from smokers, viral RIG-I and TLR3 mRNA induction was reduced
87 and 79 % compared to the response from nonsmokers. CS exposure history was associated with inhibition of
viral induction of the IFN-β, IFN-λ1 and IFN-λ 2/3 mRNA response by 85, 96 and 95 %, respectively, from that seen
in HBEC from nonsmokers. The demethylating agent 5-Aza-2-deoxycytidine reversed the immunosuppressive effects
of CS exposure in HBEC since viral induction of all three IFNs was restored. IFN-β induction of RIG-I and TLR3 was
also suppressed in the cells from smokers.
Conclusion: Our results suggest that active smoking reduces expression of antiviral cytokines in primary HBEC cells.
This effect likely occurs via downregulation of RIG-I and TLR3 due to smoke-induced epigenetic modifications.
Reduction in lung epithelial cell RIG-I and TLR3 responses may be a major mechanism contributing to the increased
risk and severity of viral respiratory infections in smokers and to viral-mediated acute exacerbations of COPD.
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Background
Chronic obstructive pulmonary disease (COPD) is a
major worldwide cause of morbidity and mortality. Ac-
cording to the World Health Organization, by 2030,
COPD will be the third most common global cause of
death [1]. Cigarette smoking (CS) is the main risk factor
for the development of COPD, which is a chronic
inflammatory disease characterized by progressive, par-
tially reversible airflow limitation [2]. CS alters innate
and adaptive immune responses, and it has been pro-
posed that many of the deleterious health consequences
of CS are due to its adverse immune effects [3]. Respira-
tory viral infections with influenza virus, rhinoviruses,
and respiratory syncytial virus are leading pathogens as-
sociated with COPD exacerbations, which are associated
with progressive loss of lung function [4]. In fact, 64 %
of COPD exacerbations are caused by respiratory
infections including influenza and respiratory syncytial
virus [5]. Additionally, many studies have established a
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relationship between CS and the risk of influenza infec-
tion [6, 7]. The mechanism of the increased risk and se-
verity of infections in smokers is probably multifactorial,
but certainly includes changes in alteration of immuno-
logic host defenses.
The innate immune system responds to influenza A
virus (IAV) through three classes of microbial pathogen
sensors, called pattern recognition receptors (PRRs).
Most cells use the cytosolic sensor, retinoic acid inducible
gene I (RIG-I), to detect IAV and trigger antiviral re-
sponses [8]. Endosomal based Toll-like receptors (TLRs)
are also involved in the recognition of, and response to
IAV. TLR3, a double-strand RNA sensor, may be used by
some epithelial cells to detect the viral replicative inter-
mediate dsRNA [9]. Plasmacytoid dendritic cells (pDCs)
use TLR7 to recognize influenza genomic RNA, upon
its release in late endosomes [10]. Finally, the PRR
nucleotide-binding domain and leucine-rich-repeat-con-
taining proteins (NLRP), including NLRP3 and nucleotide-
binding oligomerization domain 2 (NOD2), play multiple
roles in regulating the innate immune response during
virus infection through modulation of inflammasome
activation, antiviral activity, and priming of adaptive
immunity [11–14].
Airway epithelial cells are the primary location of
replication, and also represent the first line of defense
against IAV by eliciting an innate immune response
[15, 16]. In airway epithelial cells, RIG-I is the central
regulator of IAV-mediated induction of antiviral cytokines
[17]. TLR3 also contributes in the response to IAV in epi-
thelial cells [18]. We have demonstrated that RIG-I and
TLR3 are the two major PRRs induced by IAV infection in
A549 and human primary type II alveolar epithelial cells
(AEC) [19]. Either of them may compensate to maintain
antiviral immunity when the other signaling mechanism is
shut down. One of the major downstream products of
RIG-I and TLR3 signaling is the interferon (IFN) cytokine
family. IFNs are further divided into type I (mainly IFN-α
and β), II (IFN-γ) and III (IFN-λ) subtypes, based in part
on the differential use of unique receptors through which
they mediate signal transduction to induce antiviral ac-
tivity. Rapid production of type I and III IFN is a cen-
tral and essential component of the antiviral response
in airway epithelial cells [20, 21]. We have previously
shown that RIG-I is crucial for the induction of the
early antiviral cytokine response, and cigarette smoke
extract (CSE) inhibits the RIG-I initiated innate im-
mune response to IAV [22–24].
Although galectin-3 and the receptor for advanced gly-
cation end products (RAGE) are involved in the innate
response to IAV [25–27], there is no evidence that these
PRRs recognize IAV and initiate cytokine responses to
this virus in human epithelial cells. An extensive immu-
nohistochemical survey of normal human tissues showed
RAGE expression in type II alveolar pneumocytes, endo-
thelia and alveolar macrophages [28]. TLR7 and galection-
3 mainly recognize pathogens in dendritic cells [29]. In
this study, we will focus on the two major PRRs, RIG-I
and TLR3, that recognize IAV in epithelial cells and com-
pare antiviral cytokine induction by IAV in primary hu-
man bronchial epithelial cells (HBEC) from smokers and
nonsmokers.
Methods
Isolation of primary human bronchial epithelial cells
Human bronchial epithelial cells (HBEC) were obtained
by bronchoscopy and bronchial brushing with the writ-
ten, informed consent from both smoking and non-
smoking, healthy, adult volunteers in accordance with a
protocol approved by the Institutional Review Board of
the University of Oklahoma Health Sciences Center (IRB
# 2197). The smokers had a smoking history of at least
10 pack years with ½ to 1 pack of cigarettes per day. All
smoking and nonsmoking participants were gender, age
and ethnicity matched. Three or four separate bronchi
were brushed and the cells were rinsed from the brush
into 10 ml sterile saline until 5 × 106 to 1 × 107 cells
total were collected as determined by hemocytometer
counts for total and viable cells by trypan blue exclusion.
The HBECs were centrifuged at 400 × g for 5 min. Cells
were resuspended to 5 × 105 cells/ml in complete Bron-
chial Epithelial Cell Growth Medium (BEGM; Lonza
Group Ltd.); were seeded into collagen coated tissue cul-
ture plates (Bio-Coat, BD Biosciences) at a density of
1×105 cells/cm2 and were propagated in an incubator at
37 °C in 5 % CO2. After 24 h the cells were washed with
HBSS to remove non-adherent cells and fresh complete
BEGM was added. When the cultures were near conflu-
ence (7–10 days), the monolayers were lifted with 1x
Accutase solution and were subcultured at a 1:5 dilution.
After each passage the cells grew to confluence within 4
to 5 days, and when the cultures were split, freezer
stocks were prepared in 80 % BEGM+ 10 % fetal bovine
serum + 10 % DMSO and were stored in liquid nitrogen
vapor at −190 °C. Cells were rapidly thawed, washed
in BEGM, and cultured till confluence prior to
experiments.
Preparation of influenza virus stock
Influenza virus, A/PR/34/8 (PR8), was passaged in
Madin–Darby canine kidney (MDCK) cells. Virus was
grown in MDCK cells in DMEM/F12 with ITS+ (BD
Biosciences, Franklin Lakes, NJ) and trypsin, harvested
at 72 h postinfection and titered by plaque assay in
MDCK cells. There was no detectable endotoxin in the
final viral preparations used in the experiments as deter-
mined by limulus amebocyte lysate assay (Cambrex,
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Walkersville, MD). The lower limit of detection of this
assay is 0.1EU/ml or approximately 20 pg/ml LPS.
Preparation of CSE
One (100 mm) cigarette without filter was combusted
with a pump. The smoke was bubbled through 25 ml of
cell medium at a speed of 50 ml/min. The resulting sus-
pension was filtered through a 0.22-μm pore filter (Lida
Manufacturing, Kenosha, WI) to remove bacteria and
large particles. This solution, considered to be 100 % CSE,
was diluted and applied to cell cultures within 30 minutes
of preparation. The nicotine concentration of 100 % CSE
was 73.48 ± 1.08 μg/ml.
Measurement of mRNA expression by quantitative
real-time PCR (qRT-PCR)
Total RNA from cells was extracted using a modified
TRIzol (Invitrogen, Carlsbad, CA) protocol, spectropho-
metrically quantitated, and the integrity verified by for-
maldehyde agarose gel electrophoresis. Equal amounts
(1 μg) of RNA from each sample were used with oligo
(dT) as primers for production of cDNA (SuperScript II
First-Strand Synthesis System for RT-PCR, Invitrogen,
Carlsbad, CA). Gene specific primers for the PRRs, cyto-
kines and the β-actin housekeeping genes were used.
qRT-PCR was performed using 100 ng sample RNA
and SYBR Green (Quanta Biosciences, Gaithersburg,
MD) in a Bio-Rad CFX96™ Touch Real-Time PCR De-
tection System. Results were calculated and graphed from
the comparative CT method (ΔΔCT CT method). The
primers’ sequences were as follows: RIG-I forward 5′-
TCCTTTATGAGTATGTGGGCA -3′; RIG-I reverse 5′-
TCGGGCACAGAATATCTTTG -3′; IFN-β forward 5′-
GCTCTCCTGTTGTGCTTCTCCAC -3′; IFN-β reverse
5′- CAATAGTCTCATTCCAGCCAGTGC -3′; β-actin
forward 5′- GCCAACCGCGAGAAGATGACC-3′; β-
actin reverse 5′- CTCCTTAATGTCACGCACGATTTC-
3′; TLR3 forward 5′-GTCTGGGAACATTTCTCTTC-3′;
TLR3 reverse 5′-GATTTAAACATTCCTCTTCGC-3′;
IFN-λ1 forward 5′- CGCCTTGGAAGAGTCACTCA-3′;
IFN-λ1 reverse 5′- GAAGCCTCAGGTCCCAATTC-3′;
IFN-λ2/3 forward 5′- AGTTCCGGGCCTGTATCCAG-
3′; IFN-λ2/3 reverse 5′- GAGCCGGTACAGCCAAT
GGT-3′; IP-10 forward 5′-TCTAGAACCGTACGCTGT
ACCTGC-3′; IP-10 reverse 5′-CTGGTTTTAAGGAG
ATCT-3′; IRF7 forward 5′-CAGATCCAGTCCCAACC
AAG-3′; IRF7 reverse 5′- GTCTCTACTGCCCACCC
GTA-3′.
ELISA and multiplex immunoassay
ELISAs of IP-10 and IFN-λ2/3 cytokine protein levels in
the supernatants were all performed using commercially
available kits (R & D system, Minneapolis, MN).
siRNA transfection of HBEC
For siRNA treatment, cells were plated 24 h before treat-
ing with siRNAs (Ambion). siRNAs were diluted in
250 μl of Opti-MEM medium and mixed gently. Five μl
of Lipofectamine 2000 (Invitrogen) was added in 250 μl
Opti-MEM medium and incubated for 5 min. Diluted
siRNA and Lipofectamine 2000 were combined and
mixed gently and incubated for 20 min at RT. The
siRNA-Lipofectamine 2000 complexes were added to
each well and mixed gently. siRNA final concentration
was 20 nM. The cells were then incubated at 37 °C for
48 h prior to use in experiments.
RIG-I protein determination by immunoblotting
The cells were harvested and homogenized, and then
lysed in 500 μl of cold lysis buffer (150 mM NaCl,
50 mM Tris, pH 8.0, 10 mM EDTA, NaF, sodium pyro-
phosphate, 1 % NP-40, 0.5 % sodium deoxycholate,
0.1 % SDS, 10 μg of leupeptin/ml). Cell homogenates
were clarified by centrifugation at 10,000 × g, at 4 °C for
10 min, and the clarified lysates were mixed with SDS-
PAGE sample buffer (60 mM Tris, pH 6.8, 10 % glycerol,
Fig. 1 Isolation and culture of primary HBEC. HBEC are shown in a transmitted light image (left panel) and immune-stained for pan-cytokeratin
(right panel, green = cytokeratin, blue = nuclear DNA). The antibodies used were anti-human pan-cytokeratin rabbit polyclonal (Life Technologies,
DP010-05) and anti-rabbit IgG –Cy3 conjugate (Jackson Immuno Research Laboratories, 711-166-152). Bar = 100 μm
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2.3 % SDS) and heated to 95 °C for 5 min. The samples
were separated by 4–15 % gradient gel and electrophor-
etically transferred to polyvinylidene fluoride (PVDF)
membranes. For the detection of proteins, the mem-
branes were immunoblotted with rabbit polyclonal anti-
body specific for RIG-I (Abcam, Cambridge, MA) and
GAPDH (R & D Systems). The membranes were then
treated with horseradish peroxidase-labeled goat anti-
rabbit IgG (Cell Signaling Technology, Beverly, MA) and
chemiluminescent reagents (Pierce Biotechnology, Rock-
ford, IL). Blots were developed using the Syngene G:box
Bioimaging System and GeneTools software (Syngene,
Frederick, MD) and resultant signals were quantified
using ImageQuant software (BD/Molecular Dynamics,
Bedford, MA).
Statistical analysis
Where applicable, the data have been expressed as the
means ± standard error of the mean (SEM). Statistical
significance was determined by one-way ANOVA with
Student-Newman-Keuls post hoc correction for multiple
comparisons. Significance was considered as P < 0.05.
Results
HBEC isolated from smokers have suppressed antiviral
responses during influenza infection
We isolated and purified primary HBEC from participant
volunteers with normal lung function, and no recent
history of viral illness. The cells have the cobblestone
morphology (Fig. 1a) and positive immunostaining for
pan-cytokeratin (Fig. 1b), typical of epithelial cells. In sub-
sequent experiments described below, HBEC were sub-
cultured for approximately five days before viral
infection in order to study the innate cytokine response
to IAV PR8.
First, we compared the HBEC antiviral response to IAV
from current smokers and healthy nonsmokers. HBEC iso-
lated from smokers and nonsmokers were exposed to 6 ×
106 PFU/ml of IAV for 24 h. Virus-free diluents (mock)
were the negative controls for the experiments. As antici-
pated, IAV exposure induced a vigorous antiviral cytokine
response in HBEC from nonsmokers. Expression of the
antiviral cytokines IFN-β, IFN-λ1 and IFN-λ2/3 mRNA
were increased 7 fold, 380 fold and 240 fold, respectively,
over mock infection. However, in cells from smokers,
smoking inhibited viral induction of the IFN-β, IFN-λ1
and IFN-λ 2/3 mRNA response by 85, 96 and 95 %
(Fig. 2a-c), respectively, from that seen in HBEC from non-
smokers. IP-10 is an important antiviral chemokine due to
its ability to recruit activated monocytes, T lymphocytes
and natural killer cells to the sites of infection. The IP-10
mRNA antiviral response was also suppressed in HBEC
from smokers by 63 % (Fig. 2d). In human lung epithelial
cells, RIG-I and TLR3 are the two most important PRRs
for triggering antiviral immune responses to IAV. We then
examined the effect of prior CS exposure on RIG-I and
TLR3 mRNA expression in these cells (Fig. 3). Both RIG-I
Fig. 2 Antiviral interferons and IP-10 induced by influenza virus
infection were suppressed in HBEC isolated from smokers. After
infection of cells with IAV PR8 at the MOI of 1 for 24 h, total RNA
was extracted and cell cytokine mRNA expression was assessed by
qRT-PCR. Transcript levels of the cytokines (a) IFN-β, (b) IFN-λ1, (c)
IFN-λ2/3, and (d) IP-10 were normalized relative to the constitutively
expressed β-actin gene. CS = cigarette smoker; NS = nonsmoker. Data
were expressed as the means ± SEM from three separate experiments
from different donors. * denotes significant difference between the
indicated groups, P < 0.05
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and TLR3 had decreased IAV stimulated mRNA expres-
sion in smokers although the reduction was not statisti-
cally significant for TLR3. After 24 h of infection, IAV
induced RIG-I expression was decreased by 87 % while
TLR3 was decreased 79 % in cells from smokers. In prior
work, we have shown signaling through both RIG-I and
TLR3 is important for IFN induction by IAV in human
lung epithelial cells [19]. To determine whether RIG-I and
TLR3 signaling is important in IFN responses in HBEC,
we knocked down these PRRs in HBEC using siRNAs and
assessed IFN responses to IAV (Fig. 3c). First, we con-
firmed siRNA inhibition of RIG-I and TLR3. RIG-I and
TLR3 mRNA induction by IAV was blocked 67 and 78 %,
respectively, in the corresponding siRNA treated cells.
IFN-β mRNA induction was decreased 60 and 48 % in
RIG-I or TLR3 siRNA treated, IAV infected cells com-
pared to control siRNA treated cells. Double knockdown
of RIG-I and TLR3 almost completely blocked IFN-β in-
duction by IAV (82 % reduction). These results showed
that RIG-I and TLR3 are critical to IFN induction by IAV
in HBEC and that CS exposure inhibited RIG-I and TLR3
induction by IAV and caused immunosuppression of anti-
viral cytokine responses.
To mimic the CS effect on HBEC ex vivo, we also
treated HBEC isolated from nonsmokers with 2 % CSE,
using the same methods described earlier [23]. Cultured
cells were treated with 2 % CSE or not for 24 h prior to
infection with 6 × 106 PFU/ml of IAV. Virus-free
diluents (mock) were the negative controls for the exper-
iments. Consistent with our previous findings, pretreat-
ment of the cells with 2 % CSE decreased IAV
stimulated IFN-β, IFN-λ1 and IFN-λ 2/3 mRNA re-
sponse by 48, 61 and 85 % compared to cells without
CSE treatment (Fig. 4a-c). The effect of CSE on the
HBEC RIG-I and TLR3 response to IAV was also exam-
ined (Fig. 4d, e). CSE reduced RIG-I and TLR3 mRNA
induction by 76 and 63 %, respectively. Thus, the experi-
ments demonstrated that CSE suppresses antiviral cyto-
kine responses in IAV-infected HBEC through inhibition
of RIG-I and TLR3 induction.
To confirm the qRT-PCR result at the level of protein
expression, we determined IP-10 and IFN-λ 2/3 protein
levels in cultured cell supernatants by ELISA. Unstimu-
lated HBEC supernatants contained 22 pg/ml IP-10 and
16 pg/ml IFN-λ2/3 as basal levels. IAV infection in-
creased these levels to 105 and 51 pg/ml respectively
Fig. 3 RIG-I and TLR3 upregulation by influenza virus infection was required for IFNβ induction and was suppressed in HBEC isolated from
smokers. After infection of cells with IAV at an MOI of 1 for 24 h, total RNA was extracted and cell PRR mRNA expression was assessed by qRT-
PCR. Transcript levels of RIG-I (a) and TLR3 (b) were normalized relative to the constitutively expressed β-actin gene. (c) HBEC from nonsmokers
were first transfected with RIG-I or TLR3 siRNA for two days before IAV infection. Statistical significance was determined by ANOVA. Data were
expressed as the means ± SEM from three separate experiments from different donors. * denotes significant difference compared to data from
the IAV infected cells from nonsmokers (NS + IAV), P < 0.05
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(Fig. 5a). Cell pretreatment with 2 % CSE reduced IAV
stimulated IP-10 and IFN-λ2/3 levels to 67 pg/ml and
39 pg/ml, respectively (Fig. 5a, middle two bars). More
importantly, cells from smokers had significantly lower
IAV induced IP-10, at 37 pg/ml (p < 0.05) and much less
IFN-λ 2/3, at 17 pg/ml (no significant difference) as
compared with IAV stimulated, non-CSE exposed HBEC
from nonsmokers (Fig. 5a, right two bars labeled CS are
cells from smokers). We also confirmed that in vivo CS
exposure inhibited the viral RIG-I protein response
(Fig. 5b, CS + IAV vs. NS + IAV). Pretreatment with 2 %
CSE of cells from nonsmokers showed a comparable
suppressive effect as CS on IAV-mediated RIG-I protein
induction (Fig. 5b, NS + CSE + IAV vs. NS + IAV). These
results demonstrate CSE exposure inhibited RIG-I pro-
tein induction by influenza in cells similar to that seen
in smokers, consistent with our results that CS might
worsen viral infection through immunosuppression of
the antiviral response.
Transcription factor IRF7-dependent amplification of
type I and III IFNs is required for protection against
primary infection by IAV in humans [30]. One research
group demonstrated that CS resulted in reduced
influenza-mediated induction of IRF7 in upper respiratory
tract nasal epithelial cells (NECs) [31]. We next analyzed
the IAV induced IRF7 expression in our lower respiratory
tract cells from smokers and nonsmokers. Influenza in-
duction of IRF7 mRNA expression was significantly re-
duced by 64 % in smokers comparing to nonsmokers
(Fig. 6). CSE treatment, as compared with no CSE treat-
ment, suppressed IAV-stimulated IRF7 mRNA induction
by 65 % in HBEC from nonsmokers.
Demethylation reversed the immunosuppressive effects
of CS exposure on HBEC
Since the isolated HBEC from smokers have been pas-
saged for several generations and still maintained the
altered phenotypic response to IAV, we investigated
whether CS may have induced epigenetic changes re-
sponsible for immunosuppression in these cells. We
therefore performed experiments to ask if demethylation
reverses the inhibition of the IAV response seen in cells
from smokers. HBEC cells were preincubated with in-
creasing amounts of the demethylating agent 5-Aza-2-
deoxycytidine (5-Aza, Sigma) for 3 days before IAV
infection. 5-Aza was added freshly each day and main-
tained throughout the experiment. IFN induction was
measured at 24 h after IAV infection. As shown in Fig. 7,
Fig. 4 Antiviral cytokine and pattern recognition receptor induction by influenza virus infection was inhibited in CSE-treated HBEC isolated from
nonsmokers. HBEC were cultured in growth media with 2 % CSE for 24 h. After infection of the cells with IAV at an MOI of 1 for 24 h, total RNA
was extracted, and cell cytokine, (a-c), and PRR, (d, e), mRNA expression was assessed by qRT-PCR. Transcript levels were normalized relative to
the constitutively expressed β-actin gene. Data were expressed as the means ± SEM from three separate experiments from different donors.
* denotes significant difference between the indicated groups, P < 0.05
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exogenous 5-Aza restored the RIG-I, TLR3, IRF7, IP-10
and IFN virus response in cells from smokers in a dose-
dependent manner. After IAV infection, there was no
significant difference in RIG-I, IP-10 and IFN induction
between cells from nonsmokers and cells from smokers
treated with 7.5 μM of 5-Aza (Fig. 7). The restoration of
IP-10 and IFN-λ 2/3 responses to virus was also assessed
at the protein level by ELISA (Fig. 8). Consistently,
supernatant protein levels of the two cytokines reflected
mRNA expression changes. Thus, CS suppressed expres-
sion of RIG-I and TLR3 and resultant suppression of
antiviral cytokine responses is likely due to hypermethy-
lated silenced genes in HBEC from smokers.
Amplification of RIG-I and TLR3 induction by interferon
was suppressed in HBEC from smokers
The RIG-I pathway is induced by RNA virus infection.
Type I IFNs also stimulate antiviral responses by binding
to a shared receptor (IFNAR). Besides IFN-stimulated
gene induction by IFNα/β, the type I IFNs transcription-
ally stimulate a second phase of RIG-I and TLR3 pro-
duction. This autocrine/paracrine feedback amplification
results in type I IFN activation of an antiviral state in
nearby cells. We next sought to examine if RIG-I and
TLR3 mRNA induction by IFN-β was affected by smok-
ing. Cultured HBEC were treated with 500U/ml of IFN-
β (PBL Assay Science) without virus infection for 6 h.
The cells then were collected and mRNA induction was
determined by quantitative RT-PCR. As expected, both
RIG-I and TLR3 mRNA were significantly induced by
IFN-β in cells from nonsmokers (Fig. 9). However, in-
duction was suppressed in cells from smokers.
Discussion
RIG-I and TLR3-initiated antiviral responses in infected
human lung epithelial cells are well known for their abil-
ity to reduce viral replication, and both type I and type
III IFNs inhibit influenza replication. This suppression
was enhanced when both types of IFNs were simultan-
eously used [32]. We have previously demonstrated that
RIG-I and TLR3 are the two major PRRs induced by IAV
infection in human A549 and type II AEC [19]. In this re-
port, we demonstrated that influenza-induced antiviral
Fig. 5 HBEC isolated from smokers have impaired IAV-stimulated
antiviral cytokine and RIG-I protein induction. The cells from
nonsmokers were treated with or without 2 % CSE for 24 h. After
infection of HBEC cells from nonsmokers and smokers with IAV
at an MOI of 1 for 24 h, supernatants and cells were collected.
(a) Cytokine IP-10 and IFN λ2/3 expression in the supernatant was
assessed by ELISA. (b) RIG-I protein expression in HBEC was
detected by immunoblotting, normalized to GAPDH. Data were
expressed as the means ± SEM from four separate experiments
from different donors. * denotes significant difference compared
to data from the IAV infected cells from nonsmokers (NS + IAV),
P < 0.05. # denotes no significant difference compared to data from
the IAV infected cells from nonsmokers (NS + IAV)
Fig. 6 CS suppressed IRF7 mRNA induction by influenza virus in
HBEC from smokers. HBEC from nonsmokers were cultured in
growth media with or without 2 % CSE for 24 h. After infection of
the cells with IAV at an MOI of 1 for 24 h, total RNA was extracted
and IRF7 mRNA expression was assessed by qRT-PCR. Transcription
level was normalized relative to the constitutively expressed β-actin
gene. Data were expressed as the means ± SEM from three separate
experiments from different donors. * denotes significant difference
compared to data from the IAV infected cells from nonsmokers
(NS + IAV), P < 0.05
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cytokine responses were epigenetically inhibited in pri-
mary HBEC from smokers compared with nonsmokers.
CS affects the first lines of defense by increasing air-
way epithelial permeability, causing tissue disruption,
and decreasing mucociliary clearance [33]. Many studies
have shown that CS exerts detrimental effects on im-
munologic host defenses by inhibition of stimulated
cytokine production that may interfere with effective
and efficient antimicrobial responses [34–36]. Eddleston
et al. demonstrated that pretreatment of BEAS-2B cells
or normal human bronchial epithelial cells with CSE di-
minished IP-10 and RANTES mRNA induction by either
the viral mimic polyinosine-polycytidylic acid (Poly I:C)
or human rhinovirus 16 [37]. Another group showed
that CSE-mediated inhibition of poly I:C-induced
antiviral innate responses in human peripheral blood
mononuclear cells (PBMC) is mainly due to inhibition
of IFN-β production [38]. Here, we directly compared the
innate response from primary HBEC obtained from
smokers with these responses from HBEC from
nonsmokers. We demonstrated that HBEC from smokers
have a diminished RIG-I and TLR3-initiated antiviral re-
sponse to influenza infection compared to nonsmokers. It
has been demonstrated that active smoking reduces both
human lung macrophage expression of TLR3, and
dsRNA-induced IP-10 production [39]. However, the ex-
pression of mRNA transcripts for nucleic acid receptors
by RT-PCR was only measured in resting macrophages
without viral stimulation. Our data showed diminished
RIG-I and TLR3 mRNA expression in HBEC with IAV
stimulation, which is more applicable to actual IAV
infection in vivo as these cells are a major site of viral
replication. Our research provides further insights into
mechanisms by which CS alters epithelial innate immune
responses to virus infection. These observations could
help to explain the increased susceptibility of cigarette-
smoking humans to severe respiratory viral infections.
Our results suggested CS also inhibits autocrine/para-
crine amplification of RIG-I and TLR3 induction by IFNs
(Fig. 9) in surrounding cells. This may occur through
Fig. 7 Demethylation restored the antiviral response to influenza virus in HBEC isolated from smokers. HBEC were treated with fresh 5 μM and
7.5 μM 5-Aza-2-deoxycytidine (5-Aza) each day for 3 days before IAV infection. After infection of the cells with IAV at an MOI of 1 for 24 h, total
RNA was extracted and mRNA expression was assessed by qRT-PCR. Transcript levels of RIG-I (a), TLR3 (b), IRF7 (c), IP-10 (d), IFN-β (e), IFN-λ1
(f) and IFN-λ2/3 (g) were normalized relative to the constitutively expressed β-actin gene. Data were expressed as the means ± SEM from three
separate experiments from different donors. * denotes significant difference compared to data from the IAV infected cells from nonsmokers
(NS + IAV), P < 0.05. # denotes no significant difference compared to data from the IAV infected cells from nonsmokers (NS + IAV)
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epigenetic modification of the promoters of RIG-I and
TLR3 by cigarette smoke, inhibiting binding of activating
transcription factors. Epigenetic modifications, mainly
DNA methylation and histone modification, regulate gene
expression by changing DNA accessibility and chromatin
structure without changing the DNA coding sequence.
DNA methylation, the attachment of methyl groups to
DNA, potentially alters gene expression profiles of CS-
exposed target cells [40, 41]. Earlier work from Jaspers et
al. found that methylation of IRF7, which is a transcrip-
tional factor in the IFN response, was associated with an
impaired antiviral defense response in human NECs from
smokers [31]. Our data supports this previous study, and
provides further mechanistic information. Using HBEC
cells from smokers, our study demonstrated that the de-
methylation agent 5-Aza reversed the suppressed RIG-I,
TLR3, IRF7 and IFN response to IAV. RIG-I and TLR3
play important roles in the recognition of, and response
to, IAV in human lung epithelial cells. Since IRF7 is down-
stream of RIG-I-initiated signaling, epigenetic modifica-
tions of RIG-I might provide another mechanism for IRF7
inhibition found by Jaspers. Our work is consisted with
previous preliminary data demonstrating that HBEC from
subjects with COPD have minimal RIG-I induction and
impaired IFN responses to IAV [42]. In our report, we ex-
amined both RIG-I and TLR3 expression and revealed
that smoke-induced epigenetic changes are responsible for
this effect. The immunosuppressive effects of CS exposure
are likely due to increased methylation (i.e., hypermethyla-
tion) of the promoters of RIG-I and TLR3. It is known
that CS alters the methylation pattern of the genome. Re-
cently, many studies have investigated epigenetic changes
relating to exposure to cigarette smoke that lead to lung
cancer [43–45]. Few studies have, however, reported on
the epigenetic changes in the human immune system that
may lead to compromised antiviral activity with resultant
enhanced viral replication and prolonged recovery. One
study found that lung tumors of patients with COPD
differ from those of patients without COPD, with differen-
tially methylated and expressed genes being mainly in-
volved in the immune response [46]. Our future studies
will focus on whether there are DNA methylation changes
in human lung epithelial cells from smokers that alter host
defense responses.
Conclusion
Taken together, we have shown CS affects the inductive
and amplification phases of the RIG-I and TLR3 medi-
ated antiviral response to IAV in lung airway epithelial
cells. We chose IAV PR8 for these studies, as this mouse
adapted virus stain is the standard H1N1 strain used in
Fig. 8 Demethylation restored IAV induced cytokine IP-10 (a) and
IFN λ2/3 (b) protein expression in supernatants of HBEC isolated
from smokers. HBEC were treated with fresh 5 μM and 7.5 μM 5-Aza
each day for 3 days before IAV infection. After infection of the cells
with IAV at an MOI of 1 for 24 h, supernatants were collected and
cytokine expression was assessed by ELISA. Data were expressed as
the means ± SEM from three separate experiments from different
donors. * denotes significant difference compared to data from the
IAV treated cells from nonsmokers, P < 0.05. # denotes no significant
difference compared to data from the IAV infected cells from
nonsmokers (NS + IAV)
Fig. 9 CS suppressed RIG-I and TLR3 transcriptional induction by
IFN-β in HBEC from smokers. After HBEC cells were treated with
500U/ml of IFN-β for 6 h, total RNA was extracted and mRNA
expression was assessed by qRT-PCR. Transcript levels of RIG-I
(a) and TLR3 (b) were normalized relative to the constitutively
expressed β-actin gene. Data were expressed as the means ± SEM
from three separate experiments from different donors. * denotes
significant difference compared to data from the IAV infected cells
from nonsmokers (NS + IAV), P < 0.05
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both human and animal studies. However, it is recog-
nized that it is not an unmodified fresh clinical isolate,
which might limit the applicability of our conclusions
relative to other IAV. Further work needs to be done to
study the epigenetic impact of CS exposure and its effect
on gene expression of important human innate immune
components.
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